echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > "Digital therapeutics" are hot, and the province will vigorously develop the document

    "Digital therapeutics" are hot, and the province will vigorously develop the document

    • Last Update: 2022-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    【Pharmaceutical Network Policies and Regulations】Recently, Hainan Province issued the "Several Measures to Accelerate the Development of Digital Therapy Industry in Hainan Province" (hereinafter referred to as the "Measures"), which implemented some details
    of the development of the digital therapy industry in Hainan Province.
    The province will support the development of
    the digital therapy industry from clinical research, registration and approval, application promotion, and payment landing.
    And plan to build Hainan into a global digital therapy innovation island, innovation resource gathering area and industrial highland through 2-3 years of efforts! The "Several Measures" make it clear that Hainan will rely on the policy advantages of the free trade port and the full-cycle policy support system of digital therapeutics to build a high-quality digital therapeutics industry cluster and actively introduce overseas digital therapeutics enterprises
    .
    As a typical multidisciplinary "intersectional" industry, digital therapeutics is attracting a large number of domestic companies in the fields of games, software, and medical care in recent years
    .
    It is reported that as early as the end of January this year, the Hainan Provincial Health Commission issued the "14th Five-Year Plan for Digital Health in Hainan Province", which listed "exploring digital therapy for trial first" as one of the main tasks of digital health development in
    Hainan Province.
    It is understood that the official emergence of digital therapeutics began in the United States
    in 2012.
    Digital therapeutics, as defined by the International Digital Therapeutics Consortium, is a software-based therapy that provides evidence-based therapeutic interventions to patients to prevent, manage or treat disease
    .
    Digital therapeutics products must undergo clinical trials to prove that they are clinically effective and safe in order to receive regulatory approval as a clinical treatment regimen that can be used stand-alone or in conjunction with drugs, devices, or other therapies
    .
    Since 2020, the wave of "digital therapeutics" has begun to sweep in the field of smart medical care, and even in the field of medicine, and has attracted the attention of many parties from the hospital, R&D and investment
    ends.
    Among them, the world's large pharmaceutical companies, including Roche, Johnson & Johnson, Pfizer, Novartis, Merck, GlaxoSmithKline, etc.
    , have been involved in digital therapeutics, established different degrees of cooperative relations (including investment, mergers and acquisitions) with more than 80 digital therapeutics companies/institutions, and carried out digital therapeutics-related business layout
    in more than 22 segmented disease fields.
    Statistics show that in 2020, 692 financing events were reached in the field of digital medicine, with a cumulative financing amount of 133.
    5 billion yuan, becoming the second only field to biomedicine
    .
    In 2021, digital health continued to ride the wind, with 465 financing events in the first half of the year alone, with a cumulative total disclosed financing of RMB111.
    03 billion, almost reaching the cumulative financing amount
    of the world in 2020.
    The analysis believes that capital's heavy bet on digital medical care actually fully reflects its optimism
    in this field.
    According to a research report released by International Market Research And Markets Reseach, the global digital therapeutics market size was $3.
    53 billion in 2020, and the global digital therapeutics market is expected to reach $10.
    62 billion by 2025, with a compound annual growth rate of 26.
    1%.

    The industry expects that in the future, with the injection of funds, the increase of scientific research investment, and the improvement of public awareness, digital therapeutics will also be able to penetrate into more pharmaceutical fields, and achieve more and more new breakthroughs
    while the market continues to expand.
    It is understood that from the perspective of disease fields, digital therapy products that have been listed have involved more than 10 disease areas, of which mental diseases, endocrine system diseases, and nervous system diseases are the main indications for digital therapy distribution areas
    .
    It is worth mentioning that in China, although digital therapy started relatively late, it has developed very rapidly, and as of June 7 this year, 17 digital therapy products have been approved
    in China.
    Among them, 9 products are products for "children's vision training and treatment", accounting for more than 50%, followed by cognitive function therapy products
    .
    Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
    to anyone.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.